Primary |
Psoriasis |
39.8% |
Pruritus |
9.6% |
Eczema |
8.4% |
Alopecia |
7.2% |
Asthma |
7.2% |
Hypersensitivity |
3.6% |
Eyelids Pruritus |
2.4% |
Hypertension |
2.4% |
Hypothyroidism |
2.4% |
Lichen Planus |
2.4% |
Product Used For Unknown Indication |
2.4% |
Rash |
2.4% |
Alopecia Areata |
1.2% |
Arthritis |
1.2% |
Arthropod Sting |
1.2% |
Blood Cholesterol Increased |
1.2% |
Dandruff |
1.2% |
Diabetes Mellitus |
1.2% |
Irritable Bowel Syndrome |
1.2% |
Mineral Supplementation |
1.2% |
|
Skin Burning Sensation |
14.3% |
Cushing's Syndrome |
7.1% |
Expired Drug Administered |
7.1% |
Syncope |
7.1% |
Vision Blurred |
7.1% |
Visual Acuity Reduced |
7.1% |
Alopecia |
3.6% |
Bursitis |
3.6% |
Dizziness |
3.6% |
Dyspnoea |
3.6% |
Eye Swelling |
3.6% |
Food Allergy |
3.6% |
Hypersensitivity |
3.6% |
Intraocular Pressure Increased |
3.6% |
Macular Oedema |
3.6% |
Migraine |
3.6% |
Muscular Weakness |
3.6% |
Off Label Use |
3.6% |
Pregnancy |
3.6% |
Psoriasis |
3.6% |
|
Secondary |
Psoriasis |
34.5% |
Pruritus |
31.0% |
Alopecia |
24.1% |
Product Used For Unknown Indication |
5.2% |
Sleep Disorder |
5.2% |
|
Off Label Use |
21.4% |
Migraine |
14.3% |
Alopecia |
7.1% |
Expired Drug Administered |
7.1% |
Haematoma |
7.1% |
Macular Oedema |
7.1% |
Oropharyngeal Pain |
7.1% |
Treatment Failure |
7.1% |
Ulcer |
7.1% |
Underdose |
7.1% |
Vision Blurred |
7.1% |
|
Concomitant |
Psoriasis |
32.0% |
Product Used For Unknown Indication |
28.7% |
Drug Use For Unknown Indication |
8.0% |
Psoriatic Arthropathy |
5.6% |
Hypertension |
3.8% |
Depression |
3.0% |
Diabetes Mellitus |
2.5% |
Anxiety |
2.1% |
Gastrooesophageal Reflux Disease |
2.0% |
Rheumatoid Arthritis |
1.9% |
Dermatitis |
1.3% |
Pain |
1.2% |
Vitamin Supplementation |
1.2% |
Blood Cholesterol Increased |
1.1% |
Multiple Myeloma |
1.0% |
Post Concussion Syndrome |
1.0% |
Blood Cholesterol |
0.9% |
Hypersensitivity |
0.9% |
Acne |
0.8% |
Arthritis |
0.8% |
|
Injection Site Pain |
9.0% |
Psoriasis |
9.0% |
Pancreatitis |
7.9% |
Vomiting |
6.7% |
Pruritus |
5.6% |
Streptococcal Infection |
5.6% |
Alopecia |
4.5% |
Complication Of Pregnancy |
4.5% |
Death |
4.5% |
Drug Ineffective |
4.5% |
Injection Site Haematoma |
4.5% |
Pneumonia Aspiration |
4.5% |
Weight Decreased |
4.5% |
White Blood Cell Count Increased |
4.5% |
Injection Site Erythema |
3.4% |
Multiple Myeloma |
3.4% |
Muscle Spasms |
3.4% |
Nausea |
3.4% |
Pneumonia |
3.4% |
Skin Exfoliation |
3.4% |
|